 NASDAQ: KZIA, an Australian oncology-focused biotechnology company, is pleased to announce the completion of a placement of ten million new fully paid ordinary shares in the Company New Shares to institutional, professional, and sophisticated investors in Australia and internationally, at a price of A0.40 per New Share Institutional Placement. The Institutional Placement will raise A4.0 million exclusive of costs. 